Transition to Ustekinumab in Patients With Moderate-To-Severe Psoriasis and Inadequate Response to Methotrexate: A Randomized Clinical Trial (TRANSIT)
British Journal of Dermatology - United Kingdom
doi 10.1111/bjd.12646
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2014
Authors
Publisher
Wiley